The Effect of Inhaled Nitric Oxide on Dyspnea and Exercise Tolerance in COPD
NCT03679312
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
140
Enrollment
OTHER
Sponsor class
Conditions
Dyspnea
Interventions
DRUG:
Nitric Oxide
DRUG:
Placebo
Sponsor
University of Alberta
Collaborators
[object Object]
[object Object]
[object Object]